BioNTech lifts COVID vaccine sales forecast to $18.7 billion

BioNTech raised its forecast for this year's COVID-19 vaccine sales to 15.9 billion euros ($18.7 billion) and said it's pushing forward plans to test its messenger RNA technology in cancer. BioNTech and partner Pfizer signed contracts to deliver some 2.2 billion ...

from Google Alert - Business https://ift.tt/3jM32XM
BioNTech raised its forecast for this year's COVID-19 vaccine sales to 15.9 billion euros ($18.7 billion) and said it's pushing forward plans to test its messenger RNA technology in cancer. BioNTech and partner Pfizer signed contracts to deliver some 2.2 billion ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize